...+ U.S.¡based LSCS Holdings Inc. (dba Dohmen Life Science Services) is recapitalizing as part of a leveraged buyout (LBO) by private equity company JLL Partners and Water Street Healthcare Partners. In conjunction with the LBO, The Access Group is merging with Dohmen, a provider of drug commercialization solutions for pharmaceutical manufacturers. + With the new debt financing, we expect pro forma adjusted leverage to be about 6.0x at the end of 2018. + We are assigning a 'B' corporate credit rating to the company. The outlook is stable. + At the same time, we are assigning a 'B' issue-level rating and '3' recovery rating to the first-lien credit facility, and a '###+' issue-level rating and '6' recovery rating to the company's second-lien debt. + Our stable rating outlook reflects our expectation that Dohmen will effectively manage the competition from larger competitors and deliver mid- to high-single-digit revenue growth in the coming years, supported by continued growth in pharmaceutical...
